May 2012

Menopausal hormone therapy may lead to blood clot related health risks

Government agency cautions against hormone replacement therapy

  • Thu, 05/31/2012 - 1:40pm

In 2009, the U.S.

Pradaxa linked to internal bleeding

EMA recommends updated Pradaxa labels

  • Tue, 05/29/2012 - 2:04pm

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) reported Friday that the number of reported fatal bleedings associated with

Study compares dabigatran to warfarin in VTE treatment

  • Tue, 05/29/2012 - 11:06am

A study conducted primarily by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy

Study shows Fosamax causes femur fractures

Take Fosamax and other bisphosphonates for 5+ years and break your thigh bone

  • Thu, 05/24/2012 - 11:58am

Bisphosphonate drugs like Fosamax, Reclast, Actonel, and Boniva have been around since the 1990s, but researchers recently questioned how long they should be used.

Nexavar fails to meet end point goal

Nexavar fails to meet endpoint goal in phase III study

  • Wed, 05/23/2012 - 1:05pm

German pharmaceutical giant Bayer AG and Onyx Pharmaceuticals, Inc., announced Tuesday that Nexavar, a drug approved to treat liver and kidney cancer, failed to meet its endpoint goal in a Phase II

Takeda Pharmaceuticals struggles to gain FDA approval

Takeda Pharmaceuticals determined to gain FDA drug approval

  • Mon, 05/14/2012 - 1:48pm

In a country bulging with 23 million people with type 2 diabetes, Avandia and its successor, Actos, were once blockbuster drugs in the U.S.

Canada adds heart warnings to Lexapro labels

  • Mon, 05/07/2012 - 4:09pm

Serotonin reuptake inhibitor Lexapro, or Cipralex, as it’s marketed in Canada, may cause heart rhythm problems. According to Health Canada, risk increases as dosage increases.

Study shows lingering side effects with breast cancer treatment

  • Mon, 05/07/2012 - 3:13pm

A University of Pennsylvania research study revealed that 60 percent of breast cancer patients suffered at least one side effect up to six years after completing treatment and 30 percent experience

Sports supplement drink manufacturers shunned by FDA

FDA issues warning to sports supplement drink manufacturers

  • Fri, 05/04/2012 - 4:48pm

Many athletes like to prepare for a game by drinking a nice energy drink beforehand, not realizing that some of these drinks have been labeled by the Food and Drug Administration as potentially